Company Filing History:
Years Active: 2022
Title: Igor Smolenov: Innovator in mRNA Vaccine Technology
Introduction
Igor Smolenov is a prominent inventor based in Cambridge, MA, known for his contributions to the field of vaccine technology. He has made significant strides in developing innovative solutions to combat viral infections through his research and inventions.
Latest Patents
Igor holds a patent for an HMPV/hPIV3 mRNA vaccine composition. This patent describes a vaccine composition that includes a chemically-modified messenger ribonucleic acid (mRNA) encoding a hMPV fusion (F) glycoprotein and a chemically-modified mRNA encoding a hPIV3 F glycoprotein. The formulation is designed in a cationic lipid nanoparticle formulation, which is crucial for inducing an antigen-specific immune response.
Career Highlights
Igor is currently employed at ModernaTX, Inc., a leading biotechnology company focused on mRNA technology. His work at Moderna has positioned him at the forefront of vaccine development, particularly in response to emerging infectious diseases.
Collaborations
Igor collaborates with talented professionals in his field, including Lori Panther and Christine Shaw. These collaborations enhance the innovative capacity of his projects and contribute to the advancement of vaccine technology.
Conclusion
Igor Smolenov's work in mRNA vaccine technology exemplifies the impact of innovation in addressing public health challenges. His contributions are vital in the ongoing efforts to develop effective vaccines against viral infections.